No Invasive Strategy Benefit at 5 Years in ISCHEMIA-CKD EXTEND

The trial speaks to the lofty high-risk status of patients with CAD. 'You're seeing in a group of patients, with largely preserved EF but advanced CKD, a mortality rate close to 40% at 5 years.'

Related Keywords

New York ,United States ,Boston ,Massachusetts ,Bangalore ,Karnataka ,India ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna , ,European Society Of Cardiology Congress ,York University Grossman School Of Medicine ,Women Hospital Heart Vascular Center ,Sripal Bangalore ,New York University Grossman School ,European Society ,Cardiology Congress ,Hospital Heart ,Vascular Center ,Medscape Cardiology ,Cv ,Ardiovascular ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Implanted Device Cardiology ,Ischemia ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,Percutaneous Coronary Intervention ,